Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis

Kidney International

Volumn 56, Issue 3, 1999, Pages 932-943

  Chen, Yung Ming ^a   Chien, Chiang Ting ^a   Hu Tsai, Mi I ^a   Wu, Kwan Dun ^a   Tsai, Chien Chen ^a   Wu, Ming Shiou ^a   Tsai, Tun Jun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti Thy1 glomerulonephritis; Extracellular matrix; Intercellular adhesion molecule 1; Mesangial cell; Monocyte macrophage

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRONECTIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PENTOXIFYLLINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; MESANGIUM CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RAT;

EID: 0032861541     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00636.x     Document Type: Article

References (58)

1. 1. Schreiner GF: The role of the macrophage in glomerular injury. Semin Nephrol 11:268-275, 1991
2. 2. El Nahas AM: Growth factors and glomerular sclerosis. Kidney Int 41 (Suppl 36):S15-S20, 1992
3. 3. Couser WG, Johnson RJ: Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 23:193-198, 1994
4. 4. Schena FP, Gesualdo L, Grandaliano G, Montinaro V: Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game? Kidney Int 52:1439-1457, 1997
5. 5. Atkins RC: Macrophages in renal injury. Am J Kidney Dis 31:45-47, 1998
6. 6. Bagchus WM, Hoedemaeker PHJ, Rozing J, Bakker WW: Glomerulonephritis induced by monoclonal anti-thyl.1 antibodies: A sequential histological and ultrastructural study in the rat. Lab Invest 55:680-687, 1986
7. 7. Iida H, Seifert R, Alpers CE, Gronwald RGK, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, Johnson RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88:6560-6564, 1991
8. 8. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwarz SM: Expressing of smooth muscle phenotype by rat mesangial cells in immune complex nephritis: α-Smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847-858, 1991
9. 9. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
10. 10. Goto S, Yamamoto T, Feng L, Yaoita E, Hirose S, Fujinaka H, Kawasaki K, Hattori R, Yui Y, Wilson CB, Fujinaka H, Kawasaki K, Hattori R, Yui Y, Wilson CB, Arakawa M, Kihara I: Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis. Am J Pathol 147:1133-1141, 1995
11. 11. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47:114-121, 1995
12. 12. Okuda S, Languino LR, Ruoslahti E, Border W: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462, 1990
13. 13. Floege JF, Eng E, Alpers CE, Lindner V, Young B, Reidy MA, Johnson RJ: Rat glomerular mesangial cells synthesize basic FGF: Release, upregulated synthesis and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 90:2362-2369, 1992
14. 14. Shankland SJ, Hugo C, Coats SR, Nangaku M, Picher RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ: Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50:1230-1239, 1996
15. 15. Wenzel U, Schneider A, Valente AJ, Abboud HE, Thaiss F, Helmchen UM, Stahl RAK: Monocyte chemoattractant protein-I mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 51:770-776, 1997
16. 16. Tesch GH, Nikolic-Paterson DJ, Metz CN, Mu W, Bacher M, Bucala R, Atkins RC, Lan HY: Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivo. J Am Soc Nephrol 9:417-424, 1998
17. 17. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416, 1992
18. 18. Manabe N, Furuya Y, Nagano N, Yagi M, Kuramitsu K, Miyamoto H: Immunohistochemical quantitation for extracellular matrix proteins in rats with glomerulonephritis induced by monoclonal anti-thy-l.1 antibody. Nephron 71:79-86, 1995
19. 19. Border WA, Okuda S, Languino L, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
20. 20. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Decorin, a natural inhibitor of transforming growth factor β, protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
21. 21. Floege J, Eng E, Young BA, Couser WG, Johnson RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43:369-380, 1993
22. 22. Narita I, Border WA, Ketteler M, Noble NA: Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 72:17-24, 1995
23. 23. Tsuboi Y, Shankland SJ, Grande JP, Walker HJ, Johnson RJ, Dousa TP: Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes type III and IV. J Clin Invest 98:262-270, 1996
24. 24. Steinmann-Niggli K, Ziswiler R, Kung M, Marti H-P: Inhibition of matrix metalloproteinases attenuates anti-Thyl.1 nephritis. J Am Soc Nephrol 9:397-407, 1998
25. 25. Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G: Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-β1 in experimental mesangioproliferative glomerulonephritis. Am J Kidney Dis 31:453-463, 1998
26. 26. Ward A, Clissold SP: Pentoxifylline, a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34:50-97, 1987
27. 27. Gillings DB: Pentoxifylline and intermittent claudication: Review of clinical trials and cost-effectiveness analyses. J Cardiovasc Pharmacol 25(Suppl 2):S44-S50, 1995
28. 28. Strieter RM, Remick DG, Ward PA, Spengler WRN, Lynch JP, Larrick J, Kunkel SL: Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 155:1230-1236, 1988
29. 29. Zabel P, Schade FU, Schlaak M: Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 187:447-463, 1993
30. 30. Rieckmann P, Weber F, Gunther A, Martin S, Bitsch A, Broocks A, Kitze B, Weber T, Borner T, Poser S: Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J Neuroimmunol 64:193-200, 1996
31. 31. Neuner P, Klosner G, Pourmojib M, Knobler R, Schwarz T: Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes. Immunology 90:435-439, 1997
32. 32. Peterson TC, Isbrucker RA, Hooper ML: In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. Immunopharmacology 28:259-270, 1994
33. 33. Duncan MR, Hasan A, Berman B: Pentoxifylline, pentifylline, and interferons decrease type I and type III procollagen mRNA levels in dermal fibroblasts: Evidence for mediation by nuclear factor 1 down-regulation. J Invest Dermatol 104:282-286, 1995
34. 34. Tsai T-J, Lin R-H, Chang C-C, Chen Y-M, Chen C-F, Ko FN, Teng CM: Vasodilator agents modulate rat glomerular mesangial cell growth and collagen synthesis. Nephron 70:91-99, 1995
35. 35. Okuda Y, Sakoda S, Fujimura H, Yanagihara T: Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells. Immunopharmacology 35:141-148, 1996
36. 36. Peterson TC: Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology 17:486-493, 1993
37. 37. Chomczynski P, Sacchi N: Single step method for RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 163:156-162, 1987
38. 38. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory Press, 1989
39. 39. Dekynck R, Jarrett JA, Chen EY, Goeddel DV: The murine transforming growth factor-β precursor. J Biol Chem 261:4377-4379, 1986
40. 40. Kita Y, Takashi T, Ligo Y, Tamatani T, Miyasaka M, Horiuchi T: Sequence and expression of rat ICAM-1. Biochim Biophys Acta 1131:108-110, 1992
41. 41. Yoshimura T, Takeya M, Takahashi K: Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines. Biochem Biophys Res Commun 174:504-509, 1991
42. 42. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
43. 43. Noble B, Ren K, Taverne J, Dipirro J, Van Liew J, Dijkstra C, Janossy G, Poulter LW: Mononuclear cells in glomeruli and cytokines in urine reflect the severity of experimental proliferative immune complex glomerulonephritis. Clin Exp Immunol 80:281-287, 1990
44. 44. Takemura T, Yoshioka K, Murakami K, Akano N, Okada M, Aya N, Maki S: Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch 424:459-464, 1994
45. 45. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H: Expression of inducible-NOS in human glomerulonephritis: The possible source is infiltrating monocytes/macrophage. Kidney Int 50:392-399, 1996
46. 46. Kawasaki K, Yaoita E, Yamamoto T, Tamatani T, Miyasaka M, Kihara I: Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 150:1074-1083, 1993
47. 47. Gesualdo L, Grandaliano G, Ranieri E, Monno R, Montinaro V, Manno C, Schena FP: Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: A pathogenetic role for monocyte chemotactic poptide-1. Kidney Int 51:155-163, 1997
48. 48. Rollins BJ, Walz A, Baggiolini M: Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in humain monocytes. Blood 78:1112-1116, 1991
49. 49. McCarthy ET, Sharma R, Sharma M, Li J-Z, Ge X-L, Dileepan KN, Savin VJ: TNF-α1 increases albumin permeability of isolated rat glomeruli through the generation of superoxide. J Am Soc Nephrol 9:433-438, 1998
50. 50. Martin CA, Dorf ME: Differential regulation of interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage cell lines. Cell Immunol 135:245-258, 1991
51. 51. Ollivier V, Parry GCN, Cobb RR, De Prost D, Mackman N: Elevated cyclic AMP inhibits NF-KB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 271:20828-20835, 1996
52. 1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody-induced glomerular injury. J Am Soc Nephrol 7:897-905, 1996
53. 53. Yang K-D, Chuen H-L, Shaio M-F: Pentoxifylline augments but does not antagonize TNF-α-mediated neuroblastoma cell differentiation: Modulation of calcium mobilization but not cAMP. Biochem Biophys Res Commun 211:1006-1014, 1995
54. 54. Oda H, Yorioka N, Yamashita K, Kushihata S, Yamakido M: Nicardipine hydrochloride suppresses DNA synthesis in human mesangial cells stimulated with recombinant human (rh) platelet-derived growth factor AA, rh interleukin-1 alpha, or rh tumor necrosis factor-alpha. Nephron 73:16-22, 1996
55. 55. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-488, 1991
56. 56. Matousovic K, Grande JP, Chini CCS, Chini EN, Dousa TP: Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells. J Clin Invest 96:401-410, 1995
57. 57. Border WA, Noble NA, Ketteler M: TGF-β: A cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. Kidney Int 47(Suppl 49):S59-S61, 1995
58. 58. Johnson RJ, Lombardi D, Eng E, Gordon K, Alpers CE, Prytzl P, Floege J, Young B, Pippin J, Couser WG, Gabbiani G: Modulation of experimental mesangial proliferative nephritis by interferon-γ. Kidney Int 47:62-69, 1995